1-9 of 9
Eric Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6325: Lineage tracing defines responding CAR T cells in patients with B cell malignancies

Zinaida Good, Mark P. Hamilton, Jay Y. Spiegel, Moksha H. Desai, Zachary J. Ehlinger, Patrick J. Quinn, Yiyun Chen, Snehit Prabhu, Shin-Heng Chiou, Sreevidya Kurra, Eric Yang, Michael G. Ozawa, Matthew J. Frank, Lori Muffly, Gursharan K. Claire, Sushma Bharadwaj, Saurabh Dahiya, Katherine A. Kong, Mark M. Davis, Sylvia K. Plevritis, Elena Sotillo, Bita Sahaf, David B. Miklos, Crystal L. Mackall
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6325.
https://doi.org/10.1158/1538-7445.AM2024-6325
Published: 22 March 2024
View article titled, Abstract 6325: Lineage tracing defines responding CAR T cells in patients with B cell malignancies
Journal Articles

Abstract 2649: A new role for the aryl hydrocarbon receptor (AhR) as a proximal mediator of immune checkpoints (PD-L1/2 and IDO1) in non-small cell lung cancer: Insights into an interferon-induced, LncRNA-and JAK/STAT-mediated signaling pathway

Brian Lara, Megan Snyder, Zhongyan Wang, Jocelyn Fimbres, Eric Yang, David H. Sherr
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2649.
https://doi.org/10.1158/1538-7445.AM2024-2649
Published: 22 March 2024
View article titled, Abstract 2649: A new role for the aryl hydrocarbon receptor (AhR) as a proximal mediator of immune checkpoints (PD-L1/2 and IDO1) in non-small cell lung cancer: Insights into an interferon-induced, LncRNA-and JAK/STAT-mediated signaling pathway
Journal Articles

Abstract 1128: Lineage tracing of CAR T cells in patients with B cell malignancies

Zinaida Good, Mark P. Hamilton, Jay Y. Spiegel, Sreevidya Kurra, Moksha H. Desai, Snehit Prabhu, Shin-Heng Chiou, Christine Y. Yeh, Yiyun Chen, Eric Yang, Michael G. Ozawa, Fang Wu, Matthew J. Frank, Lori Muffly, Gursharan K. Claire, Juliana Craig, Maria I. Iglesias, Sushma Bharadwaj, Katherine A. Kong, Dhananjay Wagh, John Coller, Mark M. Davis, Sylvia K. Plevritis, Bita Sahaf, David B. Miklos, Crystal L. Mackall
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1128.
https://doi.org/10.1158/1538-7445.AM2023-1128
Published: 04 April 2023
View article titled, Abstract 1128: Lineage tracing of CAR T cells in patients with B cell malignancies
Journal Articles

Abstract P3-03-13: Long-term heart failure risk of trastuzumab with or without anthracyclines in early stage breast cancer: A SEER-Medicare Database Analysis

Nicholas P. McAndrew, Karissa Britten, Xiaoyan Wang, Eric Yang, Sara Hurvitz, Dennis Slamon
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-03-13.
https://doi.org/10.1158/1538-7445.SABCS22-P3-03-13
Published: 01 March 2023
View article titled, Abstract P3-03-13: Long-term heart failure risk of trastuzumab with or without anthracyclines in early stage breast cancer: A SEER-Medicare Database Analysis
Journal Articles

Abstract 3603: Reverse fate mapping of CD19-targeted CAR T cells in patients with large B-cell lymphoma

Zinaida Good, Mark P. Hamilton, Jay Y. Spiegel, Sreevidya Kurra, Moksha Desai, Snehit Prabhu, Eric Yang, Michael G. Ozawa, Paul J. Hanson, Fang Wu, Matthew J. Frank, John H. Baird, Lori Muffly, Gursharan K. Claire, Juliana Craig, Katherine A. Kong, Dhananjay Wagh, John Coller, Sylvia K. Plevritis, Bita Sahaf, David B. Miklos, Crystal L. Mackall
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3603.
https://doi.org/10.1158/1538-7445.AM2022-3603
Published: 15 June 2022
View article titled, Abstract 3603: Reverse fate mapping of CD19-targeted CAR T cells in patients with large B-cell lymphoma
Journal Articles

Abstract 2958: The novel protein kinase STK17A is a direct p53 target gene that mediates response to genotoxic and nutritional stress in a cancer cell context-dependent manner

Pingping Mao, Mary Jardine, Lynn Niemaszyk, Jessica Haghkerdar, Eric Yang, Esty G. yanco, Damayanti Desai, Maroun Beyrouthy, Joanna S. Kerley-Hamilton, Sarah J. Freemantle, Michael J. Spinella
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2958.
https://doi.org/10.1158/1538-7445.AM2012-2958
Published: 15 April 2012
View article titled, Abstract 2958: The novel protein kinase STK17A is a direct p53 target gene that mediates response to genotoxic and nutritional stress in a cancer cell context-dependent manner
Journal Articles

Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Eric Yang, Adrienne Boire, Anika Agarwal, Nga Nguyen, Katie O'Callaghan, Powen Tu, Athan Kuliopulos, Lidija Covic
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6223–6231.
https://doi.org/10.1158/0008-5472.CAN-09-0187
Published: 29 July 2009
View article titled, Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
Open the PDF for Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis in another window
Includes: Supplementary data
Journal Articles

Abstract #1270: Phosphorylation of HOX11 on Threonine-247 during mitosis regulates transactivation of Cyclin B1

Xiaoyong Huang, Edwin Chen, Yanzhen Zheng, Konstantin Krutikov, Alden Chesney, Eric Yang, Margaret R. Hough
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1270.
Published: 01 May 2009
View article titled, Abstract #1270: Phosphorylation of HOX11 on Threonine-247 during mitosis regulates transactivation of Cyclin B1
Journal Articles

A cell-penetrating PAR1 antagonist promotes chemosensitivity and blocks progression of breast and ovarian cancers

Eric Yang, Anika Agarwal, Athan Kuliopulos, Lidija Covic
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 892.
Published: 01 May 2008
View article titled, A cell-penetrating PAR1 antagonist promotes chemosensitivity and blocks progression of breast and ovarian cancers